The diagnostic and clinical impact of the genetic variability of the S (surface) gene of hepatitis B virus

LaboratoriumsMedizin

Volumn 28, Issue 1, 2004, Pages 56-69

  Weber, Bernard ^a,b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Laboratoires Reunis Kutter Lieners Hastert Centre Langwies   (Luxembourg)

Author keywords

Antiviral therapy; Escape mutant; Genotype; Vaccination

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN; VITRONECTIN;

ANTIGEN DETECTION; DISEASE COURSE; DISEASE SEVERITY; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOASSAY; LIVER CELL CARCINOMA; MUTANT; NONHUMAN; PREVALENCE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VACCINATION; VIRUS DETECTION; VIRUS GENE; WESTERN EUROPE; WILD TYPE;

HEPATITIS B VIRUS;

EID: 1842482493     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2004.011     Document Type: Review

References (112)

1. Weber B, Bayer A, Kirch P, Schlüter V, Schlieper D, Melchio W. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999;37:2639-47.
2. Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg. J Clin Microbiol 2003;41:135-43.
3. Weber B. The isolated anti-HBc reactivity: New developments. J Lab Med 2002;26:451-8.
4. Norder H, Hammas B, Löfdahl S, Couroucé AM, Magnius LO. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the hepatitis B virus strains. J Gen Virol 1992;73:1201-8.
5. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. Large surface proteins of hepatitis B virus containing the pre-S sequence. J Virol 1984;52:396-402.
6. Ou JH, Rutter WJ. Regulation of secretion of the hepatitis B virus major surface antigen by the preS-1 protein. J Virol 1987;61:782-6.
7. Bruss V, Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci USA 1991;88:1059-63.
8. Ueda K, Tsurimoto T, Matsubara K. Three envelope proteins of hepatitis B virus; large S, middle S, and major S proteins needed for the formation of Dane particles. J Virol 1991;65:3521-9.
9. Le Seyec J, Chouteau P, Cannie I, Guguen-Guillouzo C, Gripon P. Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity. J Virol 1998;72:5573-8.
10. Löffler-Mary H, Dumortier J, Klentsch-Zimmer C, Prange R. Hepatitis B virus assembly is sensitive to changes in the cytosolic S loop of the envelope proteins. Virology 2000;270:358-67.
11. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepatitis 1997;4(Suppl. 1):11-20.
12. Ganem D, Varmus HE. The molecular biology of hepatitis B viruses. Annu Rev Biochem 1987;56:651-93.
13. Simmonds P. The origin and evolution of hepatitis viruses in humans. 2000 Fleming Lecture. J Gen Virol 2001;82:693-712.
14. Okamoto H, Imai M, Kametani M, Nakamura T, Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 1987;57:231-6.
15. Sterneck M, Gunther S, Gerlach J, Naoumov NV, Santantonio T, Fisher L, Rogers X et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 1997;26:754-64.
16. Gunther S, Fischer L, Pult I, Sterneck M, Will H. Naturally occurring variants of hepatitis B virus. Adv Virus Res 1999;52:125-37.
17. Yamamoto K, Horikita M, Tsuda F, Itoh K, Akahane Y, Yotsumoto S, Okamoto H, Miyakawa Y, Mayumi M. Naturally occurring escape mutants of hepatitis B with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol 1994;68:2671-6.
18. Yoon JH, Lee HS, Kim CY. Mechanisms of the undetectability of HBsAg in patients with chronic liver disease type B. Korean J Gastroenterol 1997;30:333-43.
19. Shiels MT, Taswell HF, Czaja AJ, Nelson C, Swenke P. Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. Gastreoenterology 1987;93:675-80.
20. Couroucé-Pauty AM, Plancon A, Soulier JP. Distribution of HBsAg subtypes in the world. Vox Sang 1983;35:197-211.
21. Perillo RP. Factors influencing response to interferon in chronic hepatitis B: implications for Asian and Western populations. Hepatology 1990;12:1433-5.
22. Moriya T, Kuramoto IK, Yoshizawa H, Holland PV. Distribution of hepatitis B virus genotypes among american blood donors determined with preS2 epitope linked immunosorbent assay kit. J Clin Microbiol 2002;40:877-80.
23. Okamoto H, Imai M, Tsuda F, Tanaka T, Miyakama Y, Mayumi M. Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 1987;61:3030-4.
24. Okamoto H, Tsuda F, Sakugawa H, Sastroewignjo RI, Imai M, Miyakawa Y, Mayumi M. Typing of hepatitis B virus homology in nucleotide sequence: comparison of surface antigen subtypes. J Den Virol 1988;69:2575-8.
25. Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology 1992;33:148-58.
26. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74.
27. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997;175:1285-93.
28. Arauz-Ruiz P, Norder H, Visona KA, Magnius LO. Genotype F prevails in HBV infected patients of Hispanic origin in Central America and may carry the precore stop mutant. J Med Virol 1997;51:305-12.
29. Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus strains, four of which represent two new genotypes. Virology 1994;198:489-503.
30. Sanchez LV, Maldonado M, Bastidas-Ramirez BE, Norder H, Pandu A. Genotypes and S-gene variability of mexican hepatitis B virus strains. J Med Virol 2002;68:24-32.
31. Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-9.
32. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000;33:998-1001.
33. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S and Japan HBV Genotype Research Group. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 2001;33:218-23.
34. Akuta N, Suzuki F, Kobayashi M, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment. J Hepatol 2003;38:315-2.
35. Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 2001;39:362-4.
36. Kato H, Orito E, Gish Rg, Bzowej N, Newsom M, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M. Hepatitis B e antigen in sera from individuals infected with hepatitis B virus genotype G. Hepatology 2002;35:922-9.
37. Tran A, Kremsdorf D, Capel F, Housset C, Dauguet C, Petit MA, Brechot C. Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection. J Virol 1991;65(7):3566-74.
38. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989;2(8663):588-91.
39. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990;64:1298-1303.
40. Mizokami M, Nakano T, Orito E, Tanak Y, Sakugawa H, Mukaide M, Robertson BH. Hepatitis B virus genotype assignemnt using restriction fragment length polymorphism patterns. FEBS Lett 1999;450:66-71.
41. Kremsdorf D, Garreau F, Capel F, Petit MA, Brechot C. In vivo selection of hepatitis B virus mutant with abnormal viral protein expression. J Gen Virol 1996;77:929-39.
42. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993;74(7):1341-8.
43. Kato H, Orito E, Gish RG, Sugauchi F, Suzuki S, Ueda R, Miyakawa Y, Mizokami M. Characteristics of hepatitis B virus isolates of genotype G and their phylogenetic differences from the other six genotypes (A through F). J Virol 2002;76:6131-7.
44. Zanetti AR, Tanzi E, Manzillo G, Maio G, Sbreglia C, Caporaso N, Thomas H, Zuckerman AJ. Hepatitis B variant in Europe. Lancet 1988;2:1132-3.
45. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
46. Carmann WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet 1995;345:1406-7.
47. Fujii H, Moriyama K, Sakamoto N, Kondo T, Yasuda K, Hiraizumi Y, Yamazaki M, Sakaki Y, Okochi K, Nakajima E. Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun 1992;184:1152-7.
48. Harrison TJ, Hopes EA, Oon CJ, Zanetti AR, Zuckerman AJ. Independent emergence of a vaccine-induced escape mutant of hepatitis B virus. J Hepatol 1991;13:105-7.
49. Okamoto H, Yano K, Nozaki Y, Matsui A, Miyazaki H, Yamamoto K, Tsuda F, Machida A, Mishiro S. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immunoglobulin and vaccine. Pediatr Res 1992;32:264-8.
50. Zuckerman AJ, Zuckerman JN. Molecular epidemiology of hepatitis B virus mutant. J Med Virol 1999;58:193-5.
51. Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, Hahm KB, Cho SW. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci 2001;16:359-62.
52. Oon CJ, Chen WN, Goo KS, Goh KT. Intra-familial evidence of horizontal transmission of hepatitis B virus surface antigen mutant G145R. J Infect 2000;41:260-4.
53. Chakravarty R, Neogi M, Roychowdhury S, Panda CK. Presence of hepatitis B surface antigen mutant G145R DNA in the peripheral blood leukocytes of the family members of an asymptomatic carrier and evidence of its horizontal transmission. Virus Res 2000;90:133-41.
54. Seddigh-Tonekaboni S, Waters JA, Jeffers S, Gehrke R, Ofenloch B, Horsch A, Hess G, Thomas HC, Karayiannis P. Effect of variation in the common'a'determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000;60:113-21.
55. Carman WF. Infections associated with medical intervention: hepatitis viruses and HGV. Br Med Bull 1998;54:731-48.
56. Roznovsky L, Harrison TJ, Fang ZL, Ling R, Lochman I, Orsagova I, Pliskova L. Unusual hepatitis B surface antigen variation in a child immunized against hepatitis B. J Med Virol 2000;61:11-4.
57. Ni F, Fang DX, Gan R, Li Z, Duan S, Xu Z. A new immune escape mutant of hepatitis B virus with an Asp to Ala substitution in aa144 of the envelope major protein. Res Virol 1995;146:397-407.
58. Protzer-Knolle U, Naumann U, Bartenschlager R, Berg T, Hopf U, Meyer zum Buschenfelde KH, Neuhaus P, Gerken G. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 1998;27(1):254-63.
59. Chen HB, Fang DX, LI FQ, Jing HY, Tan WG, Li SQ. A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World J Gastroenterol 2003;9:304-8.
60. Ghany MG, Ayola B, Villamil FG, Gish RG, Rojter S, Vierling JM, Lok AS. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis. Hepatology 1998;27(1):213-22.
61. Fang DX, Li FQ, Tan WG, Chen HB, Jing HY, Li SQ, Lin HJ, Zhou ZX. Transient expression and antigenic characterization of HBsAg of HBV nt551 A to G mutant. World J Gastroenterol 1999;5:73-4.
62. Oon CJ, Lim GK, Ye Z, Goh KT, Tan KL, Yo SL, Hopes E, Harrison TJ, Zuckerman AJ. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine 1995;13:699-702.
63. Kane MA. Global control of hepatitis B through universal infant immunization. In: Ellis RW, editor. Hepatitis B Vaccines in Clinical Practice. New York: Marcel Dekker 1993;309-22.
64. Bartholomeusz A, Locarinini S. Hepatitis B virus mutants and fulminant hepatitis B: Fitness plus phenotype. Hepatology 2001;34:432-5.
65. Grethe S, Monazahian M, Boehme I, Thomssen R. Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol 1998;72:7692-6.
66. Hasegawa K, Huang J, Rogers SE, Blum HE, Liang TJ. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. J Virol 1994;68:1651-9.
67. Naoumov NV, Schneider R, Grotzinger T, Jung MC, Miska S, Pape GR, Will H. Precore mutant hepatitis B virus infection and liver disease. Gastroenterology 1992;192:538-43.
68. Pollicino T, Zanetti AR, Cacciola I, Petit MA, Smedile A, Campo S, Sagliocca L, Pasquali M, Tanzi E, Longo G, Raimondo G. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology 1997;26:495-9.
69. Kalinina T, Riu A, Fischer L, Will H, Sterneck M. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis. Hepatology. 2001;34:385-94.
70. Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, editors. Fields Virology, fourth edition. Philadelphia: Lippincott Williams & Wilkins, 2001:2971-3036.
71. Rodriguez-Frias F, Brti M, Jardi R, Vargas V, Quer J, Cotrina M, Martell M, Esteban R, Guardia J. Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation. Liver 1999;19:177-82.
72. Coleman PF, Chen YC, Mushahwar IK. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 1999;59:19-24.
73. Hou, J., P. Karyiannis, J. Waters, K. Luo, C. Liang, and H. C. Thomas. 1995. A unique insertion in the S gene of surface antigen negative hepatitis B virus chinese carriers. Hepatology 21:273-8.
74. Chisari FV, Klopchin K, Moriyama T, et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B transgenic mice. Cell 1989;59:1145-56.
75. Bock CT, Tillman HL, Mashek HJ, Manns MP, Trautwein C. A preS mutation isolated from a patient with chronic hepatitis B infection leads to virus retention and missassembly. Gastroenterology 1997;113:1976-82.
76. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, Locarnini SA, Fyfe J, Sozzi T, Jackson DC. Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 2002;293:305-13.
77. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 2002;25:97-106.
78. Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF, Dienstag JL, Shinazi RF. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751-7.
79. Bock CT, Tillman HL, Torresi J, Klempnauer, Locarnini SA, Manns MP. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 2002;122:264-73.
80. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 1999;30:1312-7.
81. Carman WF, Van Deursen FJ, Mimms LT, Hardie D, Coppola R, Decker R, Sanders R. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997;26:1658-66.
82. Heijtink RA, van Bergen P, van Roosmalen MH, Sunnen CM, Paulij WP, Schalm SW, Osterhaus AD. Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg. Vaccine 2001;19:3671-80.
83. Bauer T, Weinberger K, Jilg W. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. Hepatology 2002;35:455-65.
84. Karthigesu VD, Allison LM, Ferguson M, Howard CR. A hepatitis B virus variant found in the sera of immunized children induces a conformational change in the HBsAg'a'determinant. J Med Virol 1999;58:346-52.
85. Bréchot C, Kremsdorf D, Paterlini P, Thiers V. Hepatitis B virus DNA in HBsAg-negative patients. J Hepatol 1991;14(Suppl. 4):49-55.
86. Liang TJ, Blum HE, Wands JR. Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 1990;12:204-12.
87. Preisler-Adams S, Schlayer HJ, Peters T, Hettler F, Gerok W, Rasenack J. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 1993;133:385-96.
88. 145 to Ala in the surface antigen gene. Med Sci Monit 2000;6:1165-69.
89. Chackerian B, Rudensey LM, Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus that evolve in the host after recognition by neutralizing antibodies. J Virol 1997;71:7719-27.
90. Kim KH, Lee KH, Chang HY, Ahn SH, Tong S, Yoon YJ, Seong BL, Kim SI, Han KH. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breaktrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy. J Med Virol 2003;71:367-75.
91. Kfoury Baz EM, Zheng J, Mazuruk K, Van Le A, Peterson DL. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific'a' determinant conformation change and its application in diagnostic assays. Transfusion Medicine 2001;11:355-62.
92. Banerjee K, Guptan RC, Bisht R, Sarin SK, Khandekar P. Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient. Virus Res 1999;65:103-9.
93. Cabrerizo M, Bartolom J, Caramelo C, Barril G, Carreno V. Molecular analysis of hepatitis B virus B DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000;32:116-23.
94. Le Pogam S, Shih C. Influence of a putative intermolecular interaction between Core and the pre-S1 domain of the large envelope protein on hepatitis B virus secretion. J Virol 2002;76:6510-17.
95. Oon CJ, Chen WN, Koh S, Lim GK. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J Infect Dis 1999;179:259-63.
96. Kao JH, Chen PJ, Lai MY, Chen DS. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection. J Med Virol 2002;68:216-20.
97. Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 2002;35:1215-24.
98. Carman WF. Molecular variants of hepatitis B virus. Clin Lab Med 1996;16:407-28.
99. Schories M, Peters T, Rasenack J. Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection. J Hepatol 2000;33:799-811.
100. Weber B, Melchior W, Gehrke R, Berger A, Rabenau HF. Hepatitis B virus (HBV) markers in isolated anti-HBc positive individuals. J Med Virol 2002;64:312-9.
101. Weinberger KM, Kreuzpainter EA, Hottenträger B, Neifer S, Jilg W. Mutations in the s-gene of hepatitis B virus isolates from chronic carriers with anti-HBc as the only serological marker of HBV infection. In Rizetto M, Purcell RH, Gerin JL, Verne G, editors. Viral hepatitis and liver disease. Torino: Edizioni Minerva Medica, 1997;138-43.
102. Weinberger KM, Zoulek G, Bauer T, Bohm S, Jilg W. A novel deletion mutant of hepatitis B virus surface antigen. J Med Virol 1999;58:105-10.
103. Shinji T, Koide N, Hanafusa T, Hada H, Oka T, Takayama N, Shiraha H, Nakamura M, Ujike K, Yumoto Y, Tsuji T. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen. Hepatogastroenterology 1998;45:500-2.
104. Waters J, Kennedy M, Voet P, Hauser P, Petre J, Carman W, Thomas HC. Loss of the common 'a' determinant of hepatitis B surface antigen by a vaccine induced escape mutant. J Clin Invest 1992;90:2543-7.
105. Bruce SA, Murray K. Mutations of some critical amino acid residues in the hepatitis B virus surface antigen. J Med Virol 1995;46:157-61.
106. Jilg, W., E. Sieger, R. Zachoval, and H. Schätzl. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995;23:14-20.
107. Hoofnagle JH, Seeff LB, Bales ZB, Zimmermann HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-83.
108. Rakela J, Mosley JW, Aach RD, Gitnick GL, Hollinger FB, Stevens CE, Szmuness W. Viral hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. Gastroenterology 1980;78:1318.
109. Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, Iwatsuki S, Montalvo E, Rakela J, Fung JJ: Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997;64:1582-4.
110. Weber B, Gurtler L, Thorstensson R, Michl U, Muhlbacher A, Burgisser P, Villaescusa R, Eiras A, Gabriel C, Stekel H, Tanprasert S, Oota S, Silvestre MJ, Marques C, Ladeira M, Rabenau H, Berger A, Schmitt U, Melchior W. Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity. J Clin Microbiol 2002;40:1938-46.
111. Ijaz S, Torre F, Tedder RS, Williams R, Naoumov NV. Novel immunoassay for the detection of hepatitis B surface'escape' mutants and its application in liver transplant recipients. J Med Virol. 2001;63:210-6.
112. Zhang M, Gong Y, Osiowy C, Minuk GY. Rapid detection of hepatitis B virus mutations using real-time PCR and melting curve analysis. Hepatology 2003;26:723-8.